70 likes | 214 Views
Rheumatology Therapeutics Market to 2018 - Increasing Uptake
E N D
20% Off || Hurry !! || Rheumatology Therapeutics Market to 2018 - Increasing || Aarkstore.inhttp://aarkstore.in/Rheumatology-Therapeutics-Market-2018-Increasing-Uptake.html You can also request for sample page of above mention reports on Customersupport@aarkstore.com
Pages : 120PDF - $ 3500 | Site Licence - $ 7000 | Enterprise License - $ 10500 • 20% Off on above 1000$ Reports 25% off on purchase of 2 reports and 30% on purchase of 3 or more reports. • Discount till 31st Dec. 2012.
SummaryGBI Research, the leading business intelligence provider, has released its latest research, “Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth”. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines global treatment usage patterns for various rheumatology disorders. It also looks at the geographical distribution of the rheumatology disorders therapeutics market across key geographies (the US, the top five countries of Europe, and Japan) and provides insights into the R&D pipeline and promising future blockbusters until 2018. The report also profiles major biopharmaceutical companies in the segment and analyzes M&A activity and licensing agreements. The reports covers Rheumatoid Arthritis (RA), Osteoarthritis (OA), Systemic Lupus Erythematosus (SLE) and gout, as these are most prevalent forms of rheumatologic disease. The global rheumatology therapeutics market was estimated to be worth $17.1 billion in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 9.4% from 2005, and is forecast to grow at a CAGR of 4.8% to $23.8 billion by 2018.
Scope - Data and analysis for the rheumatology therapeutics market in the leading geographies of the world: the US, the UK, Germany, France, Italy, Spain and Japan - Annualized market data for the rheumatology therapeutics market from 2005 to 2011, forecast to 2018 - In-depth analysis of the acute and chronic rheumatology therapeutics markets - Market data for the geographical and therapeutic landscapes, including size, annual cost of therapy, revenues, and treatment usage patterns for the diseased population, treatment-seeking population, diagnosed population and prescription population Reasons to buy - Build effective strategies for launching pipeline products by identifying potential geographies - Exploit in-licensing and out-licensing opportunities by identifying products to fill portfolio gaps - Develop key strategic initiatives by studying top competitors’ key strategies - Develop market-entry and market-expansion strategies by identifying the geographic markets poised for strong growth
Table of Contents : 1.1 List of Tables 81.2 List of Figures 92 Rheumatology Therapeutics Market to 2018 - Introduction 112.1 Introduction 113 Rheumatology Therapeutics Market to 2018 - Market Overview 123.1 Introduction 123.1.1 Revenue 143.1.2 Annual Cost of Treatment 163.1.3 Treatment Usage Pattern 184 Rheumatology Therapeutics Market to 2018 - Geographical Landscape Revenue Analysis by Geography 204.1 The US 204.1.1 Revenue 214.1.2 Annual Cost of Treatment 224.1.3 Treatment Usage Patterns 244.2 Top Five Countries of Europe 264.2.1 Introduction 26……………..
More Discounted Reports:http://www.aarkstore.com/publishers/GBI-Research-85.htmlRheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur GrowthCaprolactam Global Market to 2020 - Growth driven by Rising Demand from Nylon Fiber and Resin and Films Applications in ChinaEthylene Vinyl Acetate (EVA) Global Market to 2017 - Growth in the Asia-Pacific and North American Solar Panel Sectors to Drive DemandInnovation in the Prefilled Syringe Market - Biologics and Autoinjection Devices Shaping Future R&D TrendsGeneric Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare CostsStem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing ActivityMobile Health (mHealth) - Enhancing Healthcare and Improving Clinical OutcomesSpinal Surgery Devices Market to 2018 - New Entrants and Technological Advances to Intensify Competition in the Spinal Fusion Segment
For More details about above & other Reports plz contact : Lavanya Aarkstore.com Contact: Marketing team Mob.No.918149852585 Email: enquiry@aarkstore.com discount@aarkstore.com URL: http://www.aarkstore.com http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstore